Huron Consulting Group Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed quorum, elected eight directors, approved executive compensation, and ratified the auditor. No shareholder proposals were submitted, and the company emphasized its focus on long-term growth and value creation.
-
Q1 2026 saw 12% RBR growth, margin expansion, and record Healthcare performance. Guidance for 2026 is affirmed, with strong pipelines and robust bookings across all segments. Share repurchases accelerated, and AI investment remains a key growth driver.
Fiscal Year 2025
-
Record revenue and margin expansion in 2025, with strong growth across all segments and a robust start to 2026. Guidance for 2026 anticipates continued double-digit EPS growth, margin improvement, and significant investment in AI and digital capabilities.
-
Record Q3 results with 16.8% RVR growth and strong performance across all segments. Margin expansion, robust cash flow, and raised EPS guidance highlight continued momentum, supported by acquisitions and AI-driven offerings.
-
The conference highlighted strong 2024 growth, with healthcare and education as core sectors and a rebound in commercial. Strategic acquisitions and digital expansion support a robust outlook, with plans to double EPS by 2029 and maintain high client retention.
-
Second quarter 2025 saw record revenue growth across all segments, with strong demand in healthcare, education, and commercial markets. Full-year guidance was raised, reflecting confidence in continued growth, supported by recent acquisitions and robust sales pipelines.
-
Q1 2025 saw 11% RBR growth and a 36% net income increase, with all segments contributing. Guidance for 2025 is reaffirmed, and strong demand persists in healthcare, education, and digital commercial offerings despite ongoing regulatory and macroeconomic pressures.
-
Updated guidance targets low double-digit revenue growth, 15-17% EBITDA margins, and doubling EPS by 2029, driven by organic expansion, programmatic M&A, and a collaborative operating model. Healthcare, education, digital, and commercial segments all show strong growth trajectories, supported by disciplined capital deployment and innovation.
Fiscal Year 2024
-
Record 2024 results featured 9% RBR growth, margin expansion, and robust cash flow, led by healthcare and education. 2025 guidance projects continued growth, higher margins, and strong free cash flow, with ongoing investments in digital and advisory capabilities.
-
Q3 2024 saw 3% revenue growth, record bookings, and margin expansion, with strong performance in healthcare and education and a rebound in commercial digital. Guidance for full-year revenue and EPS was raised, supported by a robust sales pipeline and solid cash flow.
-
Healthcare and education drive the majority of revenue, with digital consulting now 43% of the mix. 2023 and Q2 2024 showed strong growth and margin expansion, supported by robust demand, especially in healthcare and education, while commercial digital projects face macro headwinds. Strategic investments in digital, talent, and M&A underpin a positive outlook.
-
Record Q2 revenues and margins were driven by strong healthcare and education growth, while commercial digital demand softened. Guidance was narrowed but raised for margins and EPS, with robust cash flow supporting debt reduction and share repurchases.